Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Item
http://www.wikidata.org/entity/Q34174558
Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected miceImproved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boostingBCG-mediated protection against Mycobacterium ulcerans infection in the mouse.Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.Risk factors for Buruli ulcer, Benin.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyMycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer diseaseNontuberculous mycobacterial osteomyelitis.Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
P2860

Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Item
http://www.wikidata.org/entity/Q34174558
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@ast
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@en
Prophylactic effect of mycobac ...... Mycobacterium ulcerans disease
@nl
type
label
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@ast
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@en
Prophylactic effect of mycobac ...... Mycobacterium ulcerans disease
@nl
prefLabel
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@ast
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@en
Prophylactic effect of mycobac ...... Mycobacterium ulcerans disease
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Prophylactic effect of mycobac ...... cerans disease (Buruli Ulcer).
@en
P2093
P2860
P304
P31
P356
10.1128/CDLI.9.6.1389-1391.2002
P433
P478
P577
P698
P921
P932